More hope than ever that half of dementia cases could be prevented – study
Lecanemab slows down early stages of the disease and is currently being assessed for approval in the UK by medicine regulators. Pharmaceutical company Eisai, and biotechnology ...
PA Media: UK News via Yahoo
14 minutes ago